iSpecimen Inc. (ISPC)
ISPC Stock Price Chart
Explore iSpecimen Inc. interactive price chart. Choose custom timeframes to analyze ISPC price movements and trends.
ISPC Company Profile
Discover essential business fundamentals and corporate details for iSpecimen Inc. (ISPC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
17 Jun 2021
Employees
24.00
Website
https://ispecimen.comCEO
Katharyn Field
Description
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
ISPC Financial Timeline
Browse a chronological timeline of iSpecimen Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
Earnings released on 15 May 2026
EPS came in at -$6.66 , while revenue for the quarter reached $156.01k .
Stock split effective on 28 Apr 2026
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 Apr 2026
EPS came in at -$23.60 surpassing the estimated -$152.00 by +84.47%, while revenue for the quarter reached $51.76k , missing expectations by -98.48%.
Earnings released on 17 Nov 2025
EPS came in at -$0.48 surpassing the estimated -$3.80 by +87.37%, while revenue for the quarter reached $106.59k , missing expectations by -96.80%.
Earnings released on 14 Aug 2025
EPS came in at -$0.42 surpassing the estimated -$3.80 by +88.95%, while revenue for the quarter reached $713.14k , missing expectations by -77.03%.
Earnings released on 19 May 2025
EPS came in at -$0.71 surpassing the estimated -$4.40 by +83.86%, while revenue for the quarter reached $1.06m , missing expectations by -58.46%.
Earnings released on 14 Apr 2025
EPS came in at -$6.28 falling short of the estimated -$4.00 by -57.00%, while revenue for the quarter reached $1.48m , missing expectations by -50.44%.
Earnings released on 7 Nov 2024
EPS came in at -$2.10 surpassing the estimated -$3.80 by +44.74%, while revenue for the quarter reached $2.66m , missing expectations by -9.67%.
Stock split effective on 16 Sept 2024
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 6 Aug 2024
EPS came in at -$3.80 surpassing the estimated -$5.60 by +32.14%, while revenue for the quarter reached $2.86m , missing expectations by -0.60%.
Earnings released on 7 May 2024
EPS came in at -$6.40 falling short of the estimated -$5.40 by -18.52%, while revenue for the quarter reached $2.29m , missing expectations by -19.48%.
Earnings released on 14 Mar 2024
EPS came in at -$6.80 falling short of the estimated -$4.80 by -41.67%, while revenue for the quarter reached $2.57m , missing expectations by -15.55%.
Earnings released on 2 Nov 2023
EPS came in at -$4.60 surpassing the estimated -$7.00 by +34.29%, while revenue for the quarter reached $2.78m , beating expectations by +24.28%.
Earnings released on 2 Aug 2023
EPS came in at -$7.80 falling short of the estimated -$6.00 by -30.00%, while revenue for the quarter reached $1.63m , missing expectations by -46.92%.
Earnings released on 4 May 2023
EPS came in at -$5.40 surpassing the estimated -$6.40 by +15.63%, while revenue for the quarter reached $2.95m , beating expectations by +12.47%.
Earnings released on 14 Mar 2023
EPS came in at -$4.80 surpassing the estimated -$7.50 by +36.00%, while revenue for the quarter reached $3.20m , beating expectations by +19.65%.
Earnings released on 8 Nov 2022
EPS came in at -$0.35 surpassing the estimated -$6.80 by +94.85%, while revenue for the quarter reached $2.58m , beating expectations by +5.45%.
Earnings released on 4 Aug 2022
EPS came in at -$6.00 falling short of the estimated -$0.28 by -2.08k%, while revenue for the quarter reached $2.34m , missing expectations by -18.51%.
Earnings released on 10 May 2022
EPS came in at -$0.27 falling short of the estimated -$0.25 by -8.00%, while revenue for the quarter reached $2.52m , missing expectations by -9.27%.
Earnings released on 17 Feb 2022
EPS came in at -$0.27 falling short of the estimated -$0.22 by -22.73%, while revenue for the quarter reached $2.55m , missing expectations by -27.20%.
Earnings released on 4 Nov 2021
EPS came in at -$4.40 , while revenue for the quarter reached $2.72m .
Earnings released on 10 Aug 2021
EPS came in at -$17.40 , while revenue for the quarter reached $2.90m .
ISPC Stock Performance
Access detailed ISPC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
